Coronavirus Update: J&J’s Single Shot Could Catch Up With Frontrunners
Phase III Trials Launched
Executive Summary
Company is confident that data readout from pivotal trial could be ready before the end of 2020.
You may also be interested in...
Coronavirus Update: Lilly To Seek EUA For Olumiant
Hot on the heels of positive news from its monoclonal antibody treatment, Lilly aims to seek emergency authorization for anti-inflammatory treatment Olumiant.
Citeline And Norstella Merge To Provide End-To-End Solutions For Pharma
Publisher’s Spotlight: Citeline, the publisher of Generics Bulletin, is to merge with fellow pharmaceutical solutions provider Norstella.
Citeline And Norstella Merge To Provide End-To-End Solutions For Pharma
Publisher’s Spotlight: Citeline, the publisher of Scrip, is to merge with fellow pharmaceutical solutions provider Norstella.